Kurmasheva, R. T., Sammons, M., Favours, E., Wu, J., Kurmashev, D., Cosmopoulos, K., . . . Smith, M. A. (2016). Initial Testing (Stage 1) of Tazemetostat (EPZ-6438), a Novel EZH2 Inhibitor, by the Pediatric Preclinical Testing Program. Pediatr Blood Cancer.
Citação norma ChicagoKurmasheva, Raushan T., et al. "Initial Testing (Stage 1) of Tazemetostat (EPZ-6438), a Novel EZH2 Inhibitor, By the Pediatric Preclinical Testing Program." Pediatr Blood Cancer 2016.
Citação norma MLAKurmasheva, Raushan T., et al. "Initial Testing (Stage 1) of Tazemetostat (EPZ-6438), a Novel EZH2 Inhibitor, By the Pediatric Preclinical Testing Program." Pediatr Blood Cancer 2016.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.